Martina Piccoli

Isolation of mesenchymal stem cells from human vermiform appendix.

Amniotic fluid and bone marrow derived mesenchymal stem cells can be converted to smooth muscle cells in the cryo-injured rat bladder and prevent compensatory hypertrophy of surviving smooth muscle cells.

Human amniotic fluid-derived stem cells are rejected after transplantation in the myocardium of normal, ischemic, immuno-suppressed or immuno-deficient rat.

Satellite cells delivered by micro-patterned scaffolds: a new strategy for cell transplantation in muscle diseases.

High transduction efficiency of human amniotic fluid stem cells mediated by adenovirus vectors.

Mesenchymal stromal cells can be derived from bone marrow CD133+ cells: implications for therapy.

Efficient delivery of human single fiber-derived muscle precursor cells via biocompatible scaffold.

Different cardiovascular potential of adult- and fetal-type mesenchymal stem cells in a rat model of heart cryoinjury.

Muscle differentiation and myotubes alignment is influenced by micropatterned surfaces and exogenous electrical stimulation.

The influence of heart valve leaflet matrix characteristics on the interaction between human mesenchymal stem cells and decellularized scaffolds.

In vitro and in vivo cardiomyogenic differentiation of amniotic fluid stem cells.

Design of a stirred multiwell bioreactor for expansion of CD34+ umbilical cord blood cells in hypoxic conditions.

Human amniotic fluid stem cell preconditioning improves their regenerative potential.

Amniotic fluid stem cells restore the muscle cell niche in a HSA-Cre, Smn(F7/F7) mouse model.

Sources of Mesenchymal Stem Cells: Current and Future Clinical Use.

Hypoxia increases mouse satellite cell clone proliferation maintaining both in vitro and in vivo heterogeneity and myogenic potential.

Amniotic fluid stem cells improve survival and enhance repair of damaged intestine in necrotising enterocolitis via a COX-2 dependent mechanism.

Isolation of c-Kit+ Human Amniotic Fluid Stem Cells from Second Trimester.

Single cell PCR analysis of murine embryonic stem cells cultured on different substrates highlights heterogeneous expression of stem cell markers.

Stem cells from fetal membranes and amniotic fluid: markers for cell isolation and therapy.

Fetal stem cells and skeletal muscle regeneration: a therapeutic approach.

Endothelial properties of third-trimester amniotic fluid stem cells cultured in hypoxia.

Isolation and Expansion of Muscle Precursor Cells from Human Skeletal Muscle Biopsies.

Extracellular Matrix and Colorectal Cancer: How Surrounding Microenvironment Affects Cancer Cell Behavior?